Cash flow AbbVie Inc.

Equities

ABBV

US00287Y1091

Pharmaceuticals

Market Closed - Nyse Other stock markets 21:00:03 13/02/2026 GMT			Pre-market 12:07:51
231.50 ^USD	+1.76%		234.76	+1.41%

02-13	China Medical University Hospital Collaborates with Ever Supreme Bio Technology to Develop Exosome Platform	CI
02-12	AbbVie sues US health agency over Botox price controls	RE

7a38c9a8aa657dfb69aaacd147b.WofuHLYk5iFSN4wOPRHBo_2SI-hPIc_SpB_De-RVW84.Bc6MdORuv3lnYed8CX2T857cZr4bd67k-3ypAYkzNpsu5Z1JwhKzchoa1Q

Published financial data: ABBVIE INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	45.8B	56.2B	58.05B	54.32B	56.33B
Total Revenues	45.8B	56.2B	58.05B	54.32B	56.33B
Cost of Goods Sold, Total	14.06B	17.31B	16.53B	16.73B	16.69B
Gross Profit	31.75B	38.88B	41.53B	37.59B	39.64B
Selling General & Admin Expenses, Total	9.87B	11.87B	12.08B	12.9B	13.19B
R&D Expenses	6.18B	6.98B	6.49B	7.04B	8.13B
Other Operating Expenses	-	500M	-1M	-10M	-7M
Other Operating Expenses, Total	16.05B	19.35B	18.57B	19.93B	21.31B
Operating Income	15.7B	19.53B	22.96B	17.66B	18.33B
Interest Expense, Total	-2.45B	-2.42B	-2.23B	-2.22B	-2.81B
Interest And Investment Income	174M	39M	186M	540M	648M
Net Interest Expenses	-2.28B	-2.38B	-2.04B	-1.68B	-2.16B
Currency Exchange Gains (Loss)	-71M	-51M	-148M	-146M	-21M
Other Non Operating Income (Expenses)	113M	55M	142M	190M	271M
EBT, Excl. Unusual Items	13.46B	17.15B	20.91B	16.02B	16.42B
Restructuring Charges	-	-	-	-	-
Merger & Related Restructuring Charges	-3.11B	-587M	-768M	-119M	-792M
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-	68M	172M	-	-
Asset Writedown	-	-	-876M	-4.23B	-4.48B
In Process R&D Expenses	-1.2B	-962M	-697M	-778M	-2.76B
Legal Settlements	-	-	-2.5B	485M	-910M
Other Unusual Items	-5.75B	-2.68B	-2.76B	-5.13B	-3.77B
EBT, Incl. Unusual Items	3.4B	12.99B	13.48B	6.25B	3.72B
Income Tax Expense	-1.22B	1.44B	1.63B	1.38B	-570M
Earnings From Continuing Operations	4.62B	11.55B	11.84B	4.87B	4.29B
Net Income to Company	4.62B	11.55B	11.84B	4.87B	4.29B
Minority Interest	-6M	-7M	-9M	-10M	-8M
Net Income - (IS)	4.62B	11.54B	11.84B	4.86B	4.28B
Preferred Dividend and Other Adjustments	60M	74M	54M	43M	40M
Net Income to Common Incl Extra Items	4.56B	11.47B	11.78B	4.82B	4.24B
Net Income to Common Excl. Extra Items	4.56B	11.47B	11.78B	4.82B	4.24B
Per Share Items
Net EPS - Basic	2.73	6.48	6.65	2.73	2.4
Basic EPS - Continuing Operations	2.73	6.48	6.65	2.73	2.4
Basic Weighted Average Shares Outstanding	1.67B	1.77B	1.77B	1.77B	1.77B
Net EPS - Diluted	2.72	6.45	6.63	2.72	2.39
Diluted EPS - Continuing Operations	2.72	6.45	6.63	2.72	2.39
Diluted Weighted Average Shares Outstanding	1.67B	1.78B	1.78B	1.77B	1.77B
Normalized Basic EPS	5.04	6.05	7.37	5.66	5.8
Normalized Diluted EPS	5.03	6.03	7.34	5.64	5.78
Dividend Per Share	4.84	5.31	5.71	5.99	6.29
Payout Ratio	167.16	80.24	84.85	216.72	257.71
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	22.17B	28.05B	31.42B	26.36B	26.72B
EBITA	21.5B	27.25B	30.65B	25.61B	25.95B
EBIT	15.7B	19.53B	22.96B	17.66B	18.33B
EBITDAR	22.48B	28.4B	31.76B	26.66B	27.06B
Effective Tax Rate - (Ratio)	-36.02	11.09	12.11	22.03	-15.34
Current Domestic Taxes	907M	1.99B	2.65B	3.27B	-331M
Current Foreign Taxes	194M	351M	916M	994M	1.21B
Total Current Taxes	1.1B	2.34B	3.56B	4.27B	879M
Deferred Domestic Taxes	-58M	-839M	-1.51B	-2.32B	-1.3B
Deferred Foreign Taxes	-2.27B	-59M	-419M	-565M	-146M
Total Deferred Taxes	-2.32B	-898M	-1.93B	-2.89B	-1.45B
Normalized Net Income	8.41B	10.71B	13.06B	10B	10.26B
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	-	-	-	-	2.81B
Non-Cash Pension Expense	-82M	-136M	-182M	-274M	-282M
Supplemental Operating Expense Items
Advertising Expense	1.8B	2.1B	2B	2.2B	2.1B
Selling and Marketing Expenses	1.8B	2.1B	2B	2.2B	2.1B
Research And Development Expense From Footnotes	7.76B	8.05B	7.21B	8.45B	15.55B
Net Rental Expense, Total	311M	353M	339M	305M	347M
Imputed Operating Lease Interest Expense	79.16M	83.09M	85.07M	86.71M	122M
Imputed Operating Lease Depreciation	232M	270M	254M	218M	225M
Stock-Based Comp., COGS (Total)	47M	46M	38M	46M	91M
Stock-Based Comp., R&D Exp. (Total)	247M	226M	232M	278M	525M
Stock-Based Comp., SG&A Exp. (Total)	459M	420M	401M	423M	805M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	753M	692M	671M	747M	1.42B

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	8.45B	9.75B	9.2B	12.81B	5.52B
Short Term Investments	30M	84M	28M	2M	31M
Trading Asset Securities, Total	7M	-	-	-	-
Total Cash And Short Term Investments	8.49B	9.83B	9.23B	12.82B	5.56B
Accounts Receivable, Total	8.82B	9.98B	11.25B	11.16B	10.92B
Other Receivables	-	-	-	-	-
Total Receivables	8.82B	9.98B	11.25B	11.16B	10.92B
Inventory	3.31B	3.13B	3.58B	4.1B	4.18B
Prepaid Expenses	3.5B	4.77B	4.31B	4.87B	4.76B
Other Current Assets, Total	51M	226M	88M	66M	165M
Total Current Assets	24.17B	27.93B	28.46B	33B	25.58B
Gross Property Plant And Equipment	11.75B	11.49B	11.72B	12.38B	12.99B
Accumulated Depreciation	-5.61B	-5.62B	-6.05B	-6.65B	-7.13B
Net Property Plant And Equipment	6.14B	5.87B	5.67B	5.73B	5.86B
Long-term Investments	424M	318M	241M	304M	279M
Goodwill	33.12B	32.38B	32.16B	32.29B	34.96B
Other Intangibles, Total	82.88B	75.95B	67.44B	55.61B	60.07B
Other Long-Term Assets, Total	3.82B	4.08B	4.83B	7.77B	8.42B
Total Assets	151B	147B	139B	135B	135B
Liabilities
Accounts Payable, Total	2.28B	2.88B	2.93B	3.69B	2.94B
Accrued Expenses, Total	9.34B	10.7B	12.5B	15.79B	16.82B
Short-term Borrowings	34M	14M	1M	-	-
Current Portion of Long-Term Debt	8.47B	12.48B	4.14B	7.18B	6.79B
Current Portion of Leases	183M	187M	183M	181M	195M
Other Current Liabilities	8.35B	8.93B	9.78B	11.01B	12B
Total Current Liabilities	28.66B	35.19B	29.54B	37.84B	38.75B
Long-Term Debt	77.55B	64.18B	59.49B	52.46B	60.32B
Long-Term Leases	853M	738M	771M	762M	720M
Pension & Other Post Retirement Benefits	3.41B	3.15B	1.64B	1.54B	1.23B
Deferred Tax Liability Non Current	3.65B	3.01B	2.19B	1.95B	2.58B
Other Non Current Liabilities	23.34B	24.82B	27.89B	29.76B	28.2B
Total Liabilities	137B	131B	122B	124B	132B
Common Stock, Total	18M	18M	18M	18M	18M
Additional Paid In Capital	17.38B	18.3B	19.24B	20.18B	21.33B
Retained Earnings	1.06B	3.13B	4.78B	-1B	-7.9B
Treasury Stock	-2.26B	-3.14B	-4.59B	-6.53B	-8.2B
Comprehensive Income and Other	-3.12B	-2.9B	-2.2B	-2.3B	-1.92B
Total Common Equity	13.08B	15.41B	17.25B	10.36B	3.32B
Minority Interest	21M	28M	33M	37M	39M
Total Equity	13.1B	15.44B	17.29B	10.4B	3.36B
Total Liabilities And Equity	151B	147B	139B	135B	135B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.77B	1.77B	1.77B	1.77B	1.77B
ECS Total Common Shares Outstanding	1.77B	1.77B	1.77B	1.77B	1.77B
Book Value / Share	7.41	8.71	9.75	5.87	1.88
Tangible Book Value	-103B	-92.92B	-82.34B	-77.54B	-91.7B
Tangible Book Value Per Share	-58.31	-52.55	-46.54	-43.91	-51.95
Total Debt	87.1B	77.6B	64.58B	60.58B	68.02B
Net Debt	78.61B	67.77B	55.35B	47.76B	62.46B
Debt Equivalent of Unfunded Proj. Benefit Obligation	2.09B	1.35B	116M	-295M	-1.59B
Debt Equivalent Oper. Leases	2.49B	2.82B	2.71B	2.44B	2.78B
Minority Interest, Total (Incl. Fin. Div)	21M	28M	33M	37M	39M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	791M	1B	1B	1.1B	1.06B
Inventories - Work In Process, Total	1.2B	1.19B	1.42B	1.64B	1.95B
Inventories - Finished Goods, Total	1.32B	932M	1.16B	1.36B	1.17B
Land - (BS)	288M	287M	286M	286M	284M
Buildings, Total	2.56B	2.79B	2.74B	2.83B	2.9B
Machinery, Total	6.98B	6.85B	7.11B	7.45B	8B
Full Time Employees	47K	50K	50K	50K	55K
Accumulated Allowance for Doubtful Accounts (Supple)	262M	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	4.62B	11.54B	11.84B	4.86B	4.28B
Depreciation & Amortization - CF	666M	803M	778M	752M	764M
Amortization of Goodwill and Intangible Assets - (CF)	5.8B	7.72B	7.69B	7.95B	7.62B
Depreciation & Amortization, Total	6.47B	8.52B	8.47B	8.7B	8.39B
(Gain) Loss From Sale Of Asset	-	-68M	-172M	-	-
Asset Writedown & Restructuring Costs	1.2B	962M	1.47B	5.01B	7.23B
Stock-Based Compensation (CF)	753M	692M	671M	747M	911M
Other Operating Activities, Total	4.44B	2.45B	2.93B	711M	780M
Change In Accounts Receivable	-929M	-1.32B	-1.46B	66M	207M
Change In Inventories	-40M	-142M	-686M	-417M	-319M
Change In Accounts Payable	1.51B	1.63B	1.6B	3.84B	177M
Change In Deferred Taxes	-573M	-1.29B	542M	-488M	-3.21B
Change in Other Net Operating Assets	134M	-197M	-264M	-188M	361M
Cash from Operations	17.59B	22.78B	24.94B	22.84B	18.81B
Capital Expenditure	-798M	-787M	-695M	-777M	-974M
Cash Acquisitions	-39.61B	-1.9B	-794M	-1.22B	-20.52B
Investment in Marketable and Equity Securities, Total	1.46B	-21M	92M	-22M	482M
Other Investing Activities, Total	1.39B	366M	774M	13M	189M
Cash from Investing	-37.56B	-2.34B	-623M	-2.01B	-20.82B
Short Term Debt Issued, Total	-	-	-	-	5.01B
Long-Term Debt Issued, Total	3B	1B	2B	-	16.96B
Total Debt Issued	3B	1B	2B	-	21.97B
Short Term Debt Repaid, Total	-	-	-	-	-5.01B
Long-Term Debt Repaid, Total	-5.68B	-9.41B	-14.43B	-4.15B	-9.61B
Total Debt Repaid	-5.68B	-9.41B	-14.43B	-4.15B	-14.62B
Issuance of Common Stock	209M	244M	262M	180M	214M
Repurchase of Common Stock	-978M	-934M	-1.49B	-1.97B	-1.71B
Common Dividends Paid	-7.72B	-9.26B	-10.04B	-10.54B	-11.02B
Common & Preferred Stock Dividends Paid	-7.72B	-9.26B	-10.04B	-10.54B	-11.02B
Other Financing Activities, Total	-333M	-674M	-1.1B	-742M	-42M
Cash from Financing	-11.5B	-19.04B	-24.8B	-17.22B	-5.21B
Foreign Exchange Rate Adjustments	-5M	-97M	-62M	5M	-65M
Net Change in Cash	-31.48B	1.3B	-545M	3.61B	-7.29B
Supplemental Items
Cash Interest Paid	2.62B	2.71B	2.55B	2.47B	2.81B
Cash Income Tax Paid (Refund)	1.67B	3.65B	2.99B	4.7B	4.06B
Levered Free Cash Flow	16.86B	19.25B	22.97B	22.63B	19.98B
Unlevered Free Cash Flow	18.39B	20.76B	24.36B	24.02B	21.73B
Change In Net Working Capital	-2.16B	-133M	-1.57B	-4.31B	-1.44B
Net Debt Issued / Repaid	-2.68B	-8.41B	-12.43B	-4.15B	7.35B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	8.19	8.22	10.06	8.07	8.49
Return on Total Capital	12.33	12.63	16.41	14.44	16.13
Return On Equity %	187.7	80.95	72.4	35.2	62.29
Return on Common Equity	185.81	80.52	72.14	34.91	61.94
Margin Analysis
Gross Profit Margin %	69.31	69.19	71.53	69.21	70.37
SG&A Margin	21.54	21.13	20.82	23.76	23.41
EBITDA Margin %	48.4	49.91	54.13	48.53	47.43
EBITA Margin %	46.95	48.48	52.79	47.14	46.07
EBIT Margin %	34.27	34.75	39.54	32.51	32.54
Income From Continuing Operations Margin %	10.09	20.55	20.4	8.97	7.61
Net Income Margin %	10.08	20.54	20.39	8.95	7.59
Net Avail. For Common Margin %	9.95	20.41	20.29	8.87	7.52
Normalized Net Income Margin	18.35	19.06	22.49	18.41	18.21
Levered Free Cash Flow Margin	36.81	34.25	39.56	41.66	35.46
Unlevered Free Cash Flow Margin	40.16	36.95	41.96	44.22	38.58
Asset Turnover
Asset Turnover	0.38	0.38	0.41	0.4	0.42
Fixed Assets Turnover	9.69	9.35	10.06	9.53	9.72
Receivables Turnover (Average Receivables)	6.43	5.98	5.47	4.85	5.1
Inventory Turnover (Average Inventory)	5.49	5.38	4.93	4.36	4.03
Short Term Liquidity
Current Ratio	0.84	0.79	0.96	0.87	0.66
Quick Ratio	0.6	0.56	0.69	0.63	0.43
Operating Cash Flow to Current Liabilities	0.61	0.65	0.84	0.6	0.49
Days Sales Outstanding (Average Receivables)	56.93	61.05	66.74	75.29	71.71
Days Outstanding Inventory (Average Inventory)	66.69	67.86	74.06	83.78	90.79
Average Days Payable Outstanding	43.86	54.95	62.52	70.07	72.38
Cash Conversion Cycle (Average Days)	79.76	73.96	78.29	88.99	90.12
Long Term Solvency
Total Debt/Equity	665.01	502.7	373.59	582.66	2.02K
Total Debt / Total Capital	86.93	83.41	78.88	85.35	95.29
LT Debt/Equity	598.66	420.56	348.61	511.9	1.81K
Long-Term Debt / Total Capital	78.25	69.78	73.61	74.99	85.51
Total Liabilities / Total Assets	91.3	89.47	87.55	92.28	97.51
EBIT / Interest Expense	6.4	8.06	10.29	7.94	6.53
EBITDA / Interest Expense	9.16	11.72	14.24	11.99	9.64
(EBITDA - Capex) / Interest Expense	8.84	11.4	13.93	11.64	9.29
Total Debt / EBITDA	3.87	2.73	2.03	2.27	2.51
Net Debt / EBITDA	3.5	2.39	1.74	1.79	2.31
Total Debt / (EBITDA - Capex)	4.02	2.81	2.08	2.34	2.61
Net Debt / (EBITDA - Capex)	3.63	2.45	1.78	1.85	2.39
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	37.69	22.69	3.3	-6.44	3.71
Gross Profit, 1 Yr. Growth %	22.92	22.48	3.6	-9.48	5.46
EBITDA, 1 Yr. Growth %	41.08	26.52	6.84	-16.12	1.37
EBITA, 1 Yr. Growth %	41.01	26.71	7.12	-16.45	1.36
EBIT, 1 Yr. Growth %	14.62	24.4	9.89	-23.07	3.81
Earnings From Cont. Operations, 1 Yr. Growth %	-41.36	149.87	2.56	-58.86	-12.05
Net Income, 1 Yr. Growth %	-41.44	150.04	2.55	-58.91	-12.03
Normalized Net Income, 1 Yr. Growth %	10.67	27.41	12.93	-23.4	2.53
Diluted EPS Before Extra, 1 Yr. Growth %	-48.48	137.13	2.79	-58.97	-12.13
Accounts Receivable, 1 Yr. Growth %	62.53	13.09	12.8	-0.88	-2.12
Inventory, 1 Yr. Growth %	82.57	-5.5	14.42	14.53	2
Net Property, Plant and Equip., 1 Yr. Growth %	85.81	-4.41	-3.41	1.08	2.16
Total Assets, 1 Yr. Growth %	68.96	-2.68	-5.27	-2.95	0.33
Tangible Book Value, 1 Yr. Growth %	142.6	-9.72	-11.39	-5.83	18.26
Common Equity, 1 Yr. Growth %	-260.01	17.83	11.98	-39.96	-67.91
Cash From Operations, 1 Yr. Growth %	32	29.5	9.51	-8.44	-17.66
Capital Expenditures, 1 Yr. Growth %	44.57	-1.38	-11.69	11.8	25.35
Levered Free Cash Flow, 1 Yr. Growth %	100.26	14.17	14.25	-1.47	-11.72
Unlevered Free Cash Flow, 1 Yr. Growth %	92.93	12.88	12.7	-1.4	-9.52
Dividend Per Share, 1 Yr. Growth %	10.25	9.71	7.53	4.9	5.01
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	18.26	29.97	12.58	-1.69	-1.49
Gross Profit, 2 Yr. CAGR %	12.61	22.7	16.6	-1.67	-2.29
EBITDA, 2 Yr. CAGR %	27.27	31.33	21.9	-3.46	-3.51
EBITA, 2 Yr. CAGR %	27.55	31.32	22.32	-3.46	-3.58
EBIT, 2 Yr. CAGR %	14.75	17.08	25.07	-5.46	-4.8
Earnings From Cont. Operations, 2 Yr. CAGR %	-9.85	21.05	60.09	-35.04	-39.85
Net Income, 2 Yr. CAGR %	-9.91	21.01	60.13	-35.09	-39.88
Normalized Net Income, 2 Yr. CAGR %	12.17	16.14	29.65	-4.01	-4.95
Diluted EPS Before Extra, 2 Yr. CAGR %	-13.79	10.53	56.12	-35.06	-39.96
Accounts Receivable, 2 Yr. CAGR %	28.01	35.58	12.95	5.74	-1.5
Inventory, 2 Yr. CAGR %	43.61	31.35	3.98	14.47	8.08
Net Property, Plant and Equip., 2 Yr. CAGR %	45.97	33.27	-3.91	-1.19	1.62
Total Assets, 2 Yr. CAGR %	59.27	28.23	-3.98	-4.12	-1.32
Tangible Book Value, 2 Yr. CAGR %	50.66	48	-10.56	-8.65	5.53
Common Equity, 2 Yr. CAGR %	24.43	37.31	14.87	-18	-56.1
Cash From Operations, 2 Yr. CAGR %	14.45	30.75	19.09	0.14	-13.17
Capital Expenditures, 2 Yr. CAGR %	11.84	19.4	-6.68	-0.64	18.38
Levered Free Cash Flow, 2 Yr. CAGR %	16.55	48.21	18.98	8.02	-3.06
Unlevered Free Cash Flow, 2 Yr. CAGR %	17.8	44.98	17.13	7.18	-2.06
Dividend Per Share, 2 Yr. CAGR %	10.69	9.98	8.62	6.21	4.96
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	17.53	19.72	20.4	5.85	0.08
Gross Profit, 3 Yr. CAGR %	13.82	15.81	17.15	7.16	0.65
EBITDA, 3 Yr. CAGR %	23.48	27.02	24.55	7.62	-1.88
EBITA, 3 Yr. CAGR %	23.74	27.27	24.71	7.73	-1.88
EBIT, 3 Yr. CAGR %	15.18	17.88	17.24	6.36	-2.47
Earnings From Cont. Operations, 3 Yr. CAGR %	-4.51	26.64	14.54	1.78	-28.14
Net Income, 3 Yr. CAGR %	-4.56	26.61	14.51	1.75	-28.17
Normalized Net Income, 3 Yr. CAGR %	14.57	17.03	18.03	8.79	-1.87
Diluted EPS Before Extra, 3 Yr. CAGR %	-6.24	20.79	7.88	0	-28.17
Accounts Receivable, 3 Yr. CAGR %	20.14	22.83	27.51	8.14	3.05
Inventory, 3 Yr. CAGR %	27.29	24.91	25.45	7.39	10.16
Net Property, Plant and Equip., 3 Yr. CAGR %	29.89	26.76	19.71	-2.28	-0.09
Total Assets, 3 Yr. CAGR %	28.61	35.15	15.92	-3.64	-2.66
Tangible Book Value, 3 Yr. CAGR %	39.09	27.02	24.74	-9.01	-0.44
Common Equity, 3 Yr. CAGR %	36.89	22.19	28.29	-7.47	-40.02
Cash From Operations, 3 Yr. CAGR %	20.87	19.26	23.25	9.1	-6.19
Capital Expenditures, 3 Yr. CAGR %	14.69	7.25	7.98	-0.88	7.36
Levered Free Cash Flow, 3 Yr. CAGR %	39.46	15.75	37.87	11.73	0.99
Unlevered Free Cash Flow, 3 Yr. CAGR %	38.43	16.14	35.1	10.59	1.3
Dividend Per Share, 3 Yr. CAGR %	22.55	10.37	9.16	7.36	5.81
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	14.91	16.99	15.52	10.65	11.11
Gross Profit, 5 Yr. CAGR %	11.26	14.4	14.04	8.47	8.95
EBITDA, 5 Yr. CAGR %	18	21.01	21.69	14	10.44
EBITA, 5 Yr. CAGR %	18.32	21.27	21.98	14.14	10.44
EBIT, 5 Yr. CAGR %	12.13	15.21	17.45	8.17	5.17
Earnings From Cont. Operations, 5 Yr. CAGR %	-2.12	14.17	17.41	-3.04	-11.47
Net Income, 5 Yr. CAGR %	-2.14	14.16	17.39	-3.08	-11.5
Normalized Net Income, 5 Yr. CAGR %	10.95	15.46	18.49	8.4	5.25
Diluted EPS Before Extra, 5 Yr. CAGR %	-2.77	12.18	14.97	-5.76	-14.66
Accounts Receivable, 5 Yr. CAGR %	13.28	15.96	17.21	15.68	15
Inventory, 5 Yr. CAGR %	14	16.72	17.4	20.63	18.19
Net Property, Plant and Equip., 5 Yr. CAGR %	19.09	17.66	15.14	14.74	12.12
Total Assets, 5 Yr. CAGR %	23.2	17.26	14.42	17.81	8.69
Tangible Book Value, 5 Yr. CAGR %	28.89	18.55	16.57	11.33	16.67
Common Equity, 5 Yr. CAGR %	27.08	27.15	27.62	4.17	-16.46
Cash From Operations, 5 Yr. CAGR %	18.48	26.47	20.15	11.21	7.14
Capital Expenditures, 5 Yr. CAGR %	8.45	10.44	5.61	4.02	12.03
Levered Free Cash Flow, 5 Yr. CAGR %	19.29	28.36	29.87	12.76	17.92
Unlevered Free Cash Flow, 5 Yr. CAGR %	19.88	27.43	28.57	12.62	17.08
Dividend Per Share, 5 Yr. CAGR %	18.17	17.71	16.77	8.68	7.46